SNTISenti Biosciences Inc. Common Stock

0.3886USD-16.07%Mkt Cap: 12.10M $P/E:

Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's…

Key Statistics

Company
Market Cap12.10M $
Enterprise Value27.34M $
Revenue (TTM)55.00K $
Gross Profit-27.32M $
Net Income (TTM)-61.44M $
Revenue/Share0.0020 USD
Last Price0.3886 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees39
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-0.46
PEG
EV/EBITDA-0.55
EV/Revenue497.13
P/S246.89
P/B5.32
EPS (TTM)-1.59
EPS (Forward)-0.95
52W Range
0.33312% of range2.880
52W High2.880 USD
52W Low0.3331 USD
Profitability
Gross Margin0.00%
Oper. Margin-79370.59%
EBITDA Margin0.00%
Profit Margin-279263.64%
ROE-1099.27%
ROA-119.94%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-43.44M $
CapEx (TTM)196.00K $
FCF Margin-35671.59%
FCF Yield-162.11%
Net Debt13.76M $
Net Debt/EBITDA-0.27
Balance Sheet
Debt/Equity5.17
Current Ratio0.82
Quick Ratio0.45
Book Value/Sh0.0820 USD
Cash/Share0.2080 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateJul 18, 2024
Analyst Consensus
Rating
Target (Mean)13.50 USD
Upside (mean)+3374.0%
Target Range12.00 USD15.00 USD
$12.00+3374.0% to mean$15.00
# Analysts2
Ownership
Shares Out.31.14M
Float12.28M
Insiders47.91%
Institutions19.00%
Short Interest
Short Ratio1.7d
Short % Float3.34%
Short % Out.1.86%
Shares Short580.42K
Short (prev mo.)542.77K
Technical
SMA 500.6843 (-43.2%)
SMA 2001.041 (-62.7%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)340.83K
Avg Vol (10d)217.55K
Technical Indicators
RSI (14)38.2
MACD-0.0712
MACD Signal-0.1002
MACD Hist.+0.0290
BB Upper0.4525 USD
BB Middle0.3835 USD
BB Lower0.3145 USD
BB Width35.98%
ATR (14)0.0573 USD
Vol Ratio (20d)3.77x